ConductScience.org, home

Paper4554232

Anti-tumor immunoreactivity in patients with malignant melanoma.

Nairn RC and 6 others. Med J Aust, 1972. Cited by 65 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anti-tumor immunoreactivity in patients with malignant melanoma. Papers, record 4554232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4554232

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-tumor immunoreactivity in patients with malignant melanoma.
PubMed
Journal
Med J Aust
PubMed
Year
1972
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.88
iCite
Revised in PubMed
2009-10-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nairn RCR C
2Nind APA P
3Guli EPE P
4Davies DJD J
5Little JHJ H
6Davis NCN C
7Whitehead RHR H

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Eye NeoplasmsMajor topic
MelanomaMajor topic
Skin NeoplasmsMajor topic
Adolescent
Adult
Aged
Antigen-Antibody Reactions
Cross Reactions
Cytotoxicity Tests, Immunologic
Female
Fluorescent Antibody Technique
Humans
Lymphocytes
Male
Microscopy, Phase-Contrast
Middle Aged

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
4840894A study of cellular inflammatory reaction in human malignant melanoma, using in vitro-labelling techniques with h3-thymidine.Arch Dermatol Forsch1974https://conductscience.org/library/papers/4840894PubMed
4820944Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.Br J Cancer1974https://conductscience.org/library/papers/4820944PubMed
4611352[Comparative autoradiographic study on the stroma reaction in melanoma and basal cell epithelioma (author's transl)].Arch Dermatol Forsch1974https://conductscience.org/library/papers/4611352PubMed
4581078Lymphocyte anergy in patients with carcinoma.Br J Cancer1973https://conductscience.org/library/papers/4581078PubMed
4542343Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.Br J Cancer1973https://conductscience.org/library/papers/4542343PubMed
4205845Fluorescent antibody studies in malignant melanoma.Br J Cancer1973https://conductscience.org/library/papers/4205845PubMed
1200701Lymphocyte stimulation in the cellular inflammatory reaction of some human skin tumours.Arch Dermatol Res (1975)1975https://conductscience.org/library/papers/1200701PubMed
1174441Lymphoreticular response to a syngeneic rat tumour: gravimetric and histological studies.Br J Cancer1975https://conductscience.org/library/papers/1174441PubMed
1156516The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma.Br J Cancer1975https://conductscience.org/library/papers/1156516PubMed
1067619Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1067619PubMed
978138Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.J Exp Med1976https://conductscience.org/library/papers/978138PubMed
962991Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.Br J Cancer1976https://conductscience.org/library/papers/962991PubMed
382645The role of immunotherapy in the management of patients with malignant melanoma.World J Surg1979https://conductscience.org/library/papers/382645PubMed
91379Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays.Br J Cancer1979https://conductscience.org/library/papers/91379PubMed
49295Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes.Immunology1975https://conductscience.org/library/papers/49295PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4554232

GET https://conductscience.org/api/papers/v1/4554232/authors